NASDAQ:ABSI Absci - ABSI Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Absci Co. Please log in to your account or sign up in order to add this asset to your watchlist. $3.36 -0.05 (-1.47%) (As of 02/7/2023 12:00 AM ET) Add Compare Share Share Today's Range$3.21▼$3.4450-Day Range$2.00▼$3.4152-Week Range$1.94▼$9.68Volume702,816 shsAverage Volume481,029 shsMarket Capitalization$310.45 millionP/E RatioN/ADividend YieldN/APrice Target$10.67 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Absci MarketRank™ ForecastAnalyst RatingModerate Buy2.60 Rating ScoreUpside/Downside217.5% Upside$10.67 Price TargetShort InterestBearish7.40% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.13) to ($0.95) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.03 out of 5 starsMedical Sector529th out of 1,029 stocksCommercial Physical Research Industry10th out of 16 stocks 3.3 Analyst's Opinion Consensus RatingAbsci has received a consensus rating of Buy. The company's average rating score is 2.60, and is based on 4 buy ratings, no hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $10.67, Absci has a forecasted upside of 217.5% from its current price of $3.36.Amount of Analyst CoverageAbsci has received no research coverage in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted7.40% of the float of Absci has been sold short.Short Interest Ratio / Days to CoverAbsci has a short interest ratio ("days to cover") of 11.1, which indicates bearish sentiment.Change versus previous monthShort interest in Absci has recently decreased by 4.45%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldAbsci does not currently pay a dividend.Dividend GrowthAbsci does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ABSI. Previous Next 3.2 News and Social Media Coverage News SentimentAbsci has a news sentiment score of 0.69. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Absci this week, compared to 2 articles on an average week.Search Interest18 people have searched for ABSI on MarketBeat in the last 30 days. This is an increase of 38% compared to the previous 30 days.MarketBeat Follows7 people have added Absci to their MarketBeat watchlist in the last 30 days. This is an increase of 600% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Absci insiders have not sold or bought any company stock.Percentage Held by Insiders19.39% of the stock of Absci is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions47.59% of the stock of Absci is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Absci are expected to grow in the coming year, from ($1.13) to ($0.95) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Absci is -2.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Absci is -2.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAbsci has a P/B Ratio of 0.85. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Absci (NASDAQ:ABSI) StockAbsci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.Read More Receive ABSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Absci and its competitors with MarketBeat's FREE daily newsletter. Email Address ABSI Stock News HeadlinesJanuary 10, 2023 | finance.yahoo.comAbsci First to Create and Validate De Novo Antibodies with Zero-Shot Generative AIDecember 29, 2022 | finance.yahoo.comAbsci (NASDAQ:ABSI) shareholders have endured a 76% loss from investing in the stock a year agoFebruary 7, 2023 | Wall Street Watch Dogs (Ad)The #1 Energy Stock to BuyThe next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…December 28, 2022 | finance.yahoo.comAbsci to Participate in the 41st Annual J.P. Morgan Healthcare ConferenceNovember 23, 2022 | finance.yahoo.comAbsci to Participate in the Berenberg Discover AI SeminarNovember 17, 2022 | finance.yahoo.comAbsci to Participate in the Piper Sandler Healthcare ConferenceNovember 9, 2022 | finance.yahoo.comAbsci Reports Third Quarter 2022 Financial ResultsNovember 9, 2022 | finance.yahoo.comAbsci Corporation (ABSI) Reports Q3 Loss, Tops Revenue EstimatesFebruary 7, 2023 | Wall Street Watch Dogs (Ad)The #1 Energy Stock to BuyThe next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…November 2, 2022 | finance.yahoo.comAbsci Welcomes Meta Senior Executive to Board of DirectorsNovember 2, 2022 | finance.yahoo.comAbsci to Participate in the Stifel Healthcare ConferenceOctober 26, 2022 | finance.yahoo.comAbsci to Participate in the 31st Annual Credit Suisse Healthcare ConferenceOctober 19, 2022 | nasdaq.comInstitutional investors own a significant stake of 29% in Absci Corporation (NASDAQ:ABSI)October 4, 2022 | bizjournals.comAbsci hires Adreas Busch to lead R&D - Portland Business Journal - The Business JournalsOctober 4, 2022 | globenewswire.comAbsci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer - GlobeNewswireOctober 4, 2022 | finance.yahoo.comAbsci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation OfficerSeptember 30, 2022 | bloomberg.comCredit Suisse Rehires Health-Care Investment Banker Nikhil Goel - BloombergSeptember 28, 2022 | finance.yahoo.comInstitutional owners may consider drastic measures as Absci Corporation's (NASDAQ:ABSI) recent US$46m drop adds to long-term lossesSeptember 26, 2022 | nasdaq.comAnalysts Expect 41% Gains Ahead For VBK - NasdaqSeptember 13, 2022 | bizjournals.comOregon and Washington stock prices plummet - Portland Business Journal - The Business JournalsSeptember 3, 2022 | benzinga.com(ABSI) – Absci to Participate in the Morgan Stanley Global Healthcare Conference - BenzingaAugust 31, 2022 | markets.businessinsider.comPre-market Movers: MGAM, SNTG, FREY, BBBY, ABSI…August 30, 2022 | nasdaq.comPre-market Movers: MGAM, SNTG, FREY, BBBY, ABSI… - NasdaqAugust 24, 2022 | finance.yahoo.comAbsci to Participate at the Inaugural Gilmartin Group Emerging Growth Company ShowcaseAugust 23, 2022 | nasdaq.comImplied VBK Analyst Target Price: $282 - NasdaqAugust 20, 2022 | nasdaq.comShareholders in Absci (NASDAQ:ABSI) have lost 79%, as stock drops 12% this past week - NasdaqAugust 16, 2022 | bizjournals.comOVF hires OCF director to lead fundraising of $50M-$100M target - The Business JournalsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive ABSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Absci and its competitors with MarketBeat's FREE daily newsletter. Email Address ABSI Company Calendar Last Earnings11/09/2022Today2/07/2023Next Earnings (Estimated)3/28/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Commercial physical research Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ABSI CUSIPN/A CIK1672688 Webwww.absci.com Phone360-949-1041FaxN/AEmployees211Year FoundedN/APrice Target and Rating Average Stock Price Forecast$10.67 High Stock Price Forecast$14.00 Low Stock Price Forecast$8.00 Forecasted Upside/Downside+217.5%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($1.23) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-100,960,000.00 Net Margins-1,960.28% Pretax Margin-1,979.12% Return on Equity-33.62% Return on Assets-28.97% Debt Debt-to-Equity Ratio0.03 Current Ratio6.71 Quick Ratio6.71 Sales & Book Value Annual Sales$5.64 million Price / Sales55.02 Cash FlowN/A Price / Cash FlowN/A Book Value$3.95 per share Price / Book0.85Miscellaneous Outstanding Shares92,395,000Free Float74,480,000Market Cap$310.45 million OptionableNot Optionable Beta1.18 Key ExecutivesMr. Sean McClain (Age 32)Founder, CEO, Pres & Director Comp: $1.02MDr. Sarah Korman J.D. (Age 44)Ph.D., Chief Legal Officer & Corp. Sec. Comp: $591.47kMr. Gregory T. Schiffman CPA (Age 66)CPA, MBA, Chief Financial Officer Todd Bedrick CPASr. VP & Chief Accounting OfficerMr. Jack GoldChief Marketing OfficerMelissa Patterson Ph.D.Chief of StaffMs. Denise DettoreChief People OfficerDr. Andreas Busch Ph.D. (Age 60)Chief Innovation Officer Jonathan Eads M.S.Sr. VP of InformaticsThomas Wrona J.D.Ph.D., Sr. VP of Intellectual PropertyMore ExecutivesKey CompetitorsInotivNASDAQ:NOTVData Knights AcquisitionNASDAQ:DKDCAOmniAbNASDAQ:OABIMaxCyteNASDAQ:MXCTOcular TherapeutixNASDAQ:OCULView All CompetitorsInsiders & InstitutionsSG Americas Securities LLCBought 5,803 shares on 2/2/2023Ownership: 0.025%Simplex Trading LLCSold 51,600 shares on 2/2/2023Ownership: 0.000%D Orazio & Associates Inc.Bought 15,000 shares on 1/26/2023Ownership: 0.016%Wealth Alliance Advisory Group LLCBought 26,120 shares on 1/17/2023Ownership: 0.028%Ronald Blue Trust Inc.Sold 7,153 shares on 1/17/2023Ownership: 0.024%View All Insider TransactionsView All Institutional Transactions ABSI Stock - Frequently Asked Questions Should I buy or sell Absci stock right now? 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Absci in the last year. There are currently 1 sell rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ABSI shares. View ABSI analyst ratings or view top-rated stocks. What is Absci's stock price forecast for 2023? 5 equities research analysts have issued 1-year target prices for Absci's shares. Their ABSI share price forecasts range from $8.00 to $14.00. On average, they predict the company's share price to reach $10.67 in the next twelve months. This suggests a possible upside of 225.2% from the stock's current price. View analysts price targets for ABSI or view top-rated stocks among Wall Street analysts. How have ABSI shares performed in 2023? Absci's stock was trading at $2.10 at the beginning of the year. Since then, ABSI shares have increased by 56.2% and is now trading at $3.28. View the best growth stocks for 2023 here. When is Absci's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 28th 2023. View our ABSI earnings forecast. How were Absci's earnings last quarter? Absci Co. (NASDAQ:ABSI) released its quarterly earnings data on Wednesday, November, 9th. The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.27) by $0.03. The company earned $2.37 million during the quarter, compared to analyst estimates of $1.79 million. Absci had a negative trailing twelve-month return on equity of 33.62% and a negative net margin of 1,960.28%. When did Absci IPO? (ABSI) raised $200 million in an initial public offering on Thursday, July 22nd 2021. The company issued 12,500,000 shares at $15.00-$17.00 per share. What is Absci's stock symbol? Absci trades on the NASDAQ under the ticker symbol "ABSI." Who are Absci's major shareholders? Absci's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Wealth Alliance Advisory Group LLC (0.03%), SG Americas Securities LLC (0.02%), Ronald Blue Trust Inc. (0.02%), D Orazio & Associates Inc. (0.02%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Karen K Mcginnis, Sarah Korman, Sean Mcclain and Todd Bedrick. View institutional ownership trends. How do I buy shares of Absci? Shares of ABSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Absci's stock price today? One share of ABSI stock can currently be purchased for approximately $3.28. How much money does Absci make? Absci (NASDAQ:ABSI) has a market capitalization of $303.04 million and generates $4.78 million in revenue each year. The company earns $-100,960,000.00 in net income (profit) each year or ($1.23) on an earnings per share basis. How many employees does Absci have? The company employs 211 workers across the globe. How can I contact Absci? The official website for the company is www.absci.com. The company can be reached via phone at 360-949-1041 or via email at investors@absci.com. This page (NASDAQ:ABSI) was last updated on 2/7/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.